DE60307286D1 - Verfahren zur Herstellung von 2-Methyl Piperazine Derivaten. - Google Patents
Verfahren zur Herstellung von 2-Methyl Piperazine Derivaten.Info
- Publication number
- DE60307286D1 DE60307286D1 DE60307286T DE60307286T DE60307286D1 DE 60307286 D1 DE60307286 D1 DE 60307286D1 DE 60307286 T DE60307286 T DE 60307286T DE 60307286 T DE60307286 T DE 60307286T DE 60307286 D1 DE60307286 D1 DE 60307286D1
- Authority
- DE
- Germany
- Prior art keywords
- preparation
- methyl piperazine
- piperazine derivatives
- relates
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
- Pyridine Compounds (AREA)
- Luminescent Compositions (AREA)
Applications Claiming Priority (13)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0201881 | 2002-06-19 | ||
SE0201881A SE0201881D0 (sv) | 2002-06-19 | 2002-06-19 | Novel compounds, their use, and preparation |
US39065602P | 2002-06-21 | 2002-06-21 | |
US390656P | 2002-06-21 | ||
SE0202041A SE0202041D0 (sv) | 2002-06-28 | 2002-06-28 | Novel process |
SE0202041 | 2002-06-28 | ||
US40611902P | 2002-08-26 | 2002-08-26 | |
US406119P | 2002-08-26 | ||
SE0202516A SE0202516D0 (sv) | 2002-08-26 | 2002-08-26 | Novel compounds, their use, and preparation |
SE0202516 | 2002-08-26 | ||
US41670102P | 2002-10-07 | 2002-10-07 | |
US416701P | 2002-10-07 | ||
PCT/SE2003/001043 WO2004000829A1 (en) | 2002-06-19 | 2003-06-18 | Novel process |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60307286D1 true DE60307286D1 (de) | 2006-09-14 |
DE60307286T2 DE60307286T2 (de) | 2007-10-25 |
Family
ID=30004077
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60307286T Expired - Lifetime DE60307286T2 (de) | 2002-06-19 | 2003-06-18 | Verfahren zur Herstellung von 2-Methyl Piperazin Derivaten. |
DE60321606T Expired - Lifetime DE60321606D1 (de) | 2002-06-19 | 2003-06-18 | Piperazinylpyrazine als Modulatoren des Serotonin 5-HT2C Rezeptors |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60321606T Expired - Lifetime DE60321606D1 (de) | 2002-06-19 | 2003-06-18 | Piperazinylpyrazine als Modulatoren des Serotonin 5-HT2C Rezeptors |
Country Status (16)
Country | Link |
---|---|
EP (2) | EP1529043B1 (de) |
JP (4) | JP4592417B2 (de) |
CN (1) | CN100334082C (de) |
AT (2) | ATE398119T1 (de) |
AU (1) | AU2003237746B8 (de) |
CA (1) | CA2485532C (de) |
CY (1) | CY1106225T1 (de) |
DE (2) | DE60307286T2 (de) |
DK (2) | DK1529043T3 (de) |
ES (2) | ES2270051T3 (de) |
HK (1) | HK1080079B (de) |
NO (1) | NO20050279D0 (de) |
NZ (1) | NZ536663A (de) |
PT (2) | PT1529043E (de) |
SI (2) | SI1645558T1 (de) |
WO (1) | WO2004000829A1 (de) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1792629A4 (de) | 2004-08-25 | 2010-08-25 | Takeda Pharmaceutical | Mittel zur prävention/behandlung von stressbedingter harninkontinenz und vorsorgeuntersuchungsverfahren dafür |
EP2018863B9 (de) | 2006-05-16 | 2015-02-18 | Takeda Pharmaceutical Company Limited | Kondensierte, heterocyclische Verbindung und ihre Verwendung |
JP5317354B2 (ja) | 2007-10-16 | 2013-10-16 | 第一三共株式会社 | ピリミジルインドリン化合物 |
US20100266504A1 (en) | 2007-11-15 | 2010-10-21 | Takahiro Matsumoto | Condensed pyridine derivative and use thereof |
CA2765239C (en) | 2009-06-15 | 2018-08-07 | Takeda Pharmaceutical Company Limited | Pyrazinooxazepine derivatives |
JPWO2011071136A1 (ja) | 2009-12-11 | 2013-04-22 | アステラス製薬株式会社 | 線維筋痛症治療剤 |
GB201304811D0 (en) * | 2013-03-15 | 2013-05-01 | Proximagen Ltd | Novel treatment for hypertension |
JPWO2019131902A1 (ja) | 2017-12-27 | 2020-12-10 | 武田薬品工業株式会社 | 腹圧性尿失禁および便失禁の治療薬 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06306075A (ja) * | 1993-04-23 | 1994-11-01 | Sanwa Kagaku Kenkyusho Co Ltd | エトキシベンズアミド誘導体 |
CN1242995C (zh) * | 1999-05-21 | 2006-02-22 | 比奥维特罗姆股份公司 | 化合物,它们的用途和制备方法 |
AR032318A1 (es) * | 2000-04-13 | 2003-11-05 | Pharmacia Corp | Compuesto derivado halogenado del acido 2-amino-5,6 heptenoico; composicion farmaceutica que lo comprende y su uso en la fabricacion de un medicamento util como inhibidor de la oxido nitrico sintetasa |
CN1227237C (zh) * | 2000-11-20 | 2005-11-16 | 比奥维特罗姆股份公司 | 作为五羟色胺5-ht2受体拮抗剂的哌嗪基吡嗪化合物 |
-
2003
- 2003-06-18 DE DE60307286T patent/DE60307286T2/de not_active Expired - Lifetime
- 2003-06-18 PT PT03736405T patent/PT1529043E/pt unknown
- 2003-06-18 EP EP03736405A patent/EP1529043B1/de not_active Expired - Lifetime
- 2003-06-18 PT PT05023471T patent/PT1645558E/pt unknown
- 2003-06-18 SI SI200331283T patent/SI1645558T1/sl unknown
- 2003-06-18 DE DE60321606T patent/DE60321606D1/de not_active Expired - Lifetime
- 2003-06-18 AT AT05023471T patent/ATE398119T1/de active
- 2003-06-18 ES ES03736405T patent/ES2270051T3/es not_active Expired - Lifetime
- 2003-06-18 ES ES05023471T patent/ES2307102T3/es not_active Expired - Lifetime
- 2003-06-18 CN CNB038141612A patent/CN100334082C/zh not_active Expired - Fee Related
- 2003-06-18 EP EP05023471A patent/EP1645558B1/de not_active Expired - Lifetime
- 2003-06-18 NZ NZ536663A patent/NZ536663A/en not_active IP Right Cessation
- 2003-06-18 AT AT03736405T patent/ATE334980T1/de active
- 2003-06-18 SI SI200330493T patent/SI1529043T1/sl unknown
- 2003-06-18 JP JP2004530934A patent/JP4592417B2/ja not_active Expired - Fee Related
- 2003-06-18 AU AU2003237746A patent/AU2003237746B8/en not_active Ceased
- 2003-06-18 DK DK03736405T patent/DK1529043T3/da active
- 2003-06-18 WO PCT/SE2003/001043 patent/WO2004000829A1/en active IP Right Grant
- 2003-06-18 CA CA2485532A patent/CA2485532C/en not_active Expired - Fee Related
- 2003-06-18 DK DK05023471T patent/DK1645558T3/da active
-
2005
- 2005-01-18 NO NO20050279A patent/NO20050279D0/no not_active Application Discontinuation
-
2006
- 2006-01-04 HK HK06100135.0A patent/HK1080079B/zh not_active IP Right Cessation
- 2006-10-30 CY CY20061101556T patent/CY1106225T1/el unknown
-
2010
- 2010-01-07 JP JP2010002229A patent/JP5378241B2/ja not_active Expired - Fee Related
-
2013
- 2013-02-04 JP JP2013019444A patent/JP2013116906A/ja active Pending
- 2013-07-08 JP JP2013142942A patent/JP2013227336A/ja not_active Withdrawn
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0311494A (pt) | Novos indóis substituìdos | |
MXPA03011484A (es) | Heteroarilos multiciclicos sustituidos con quinuclidinas para el tratamiento de enfermedades. | |
EA200600294A1 (ru) | [1,8] нафтиридин-2-оны и родственные соединения для лечения шизофрении | |
SE0303180D0 (sv) | Novel compounds | |
SE0302232D0 (sv) | Novel Compounds | |
ATE373474T1 (de) | Substituierte 2-aminotetraline zur behandlung von depressionen | |
RS28004A (en) | Azabicycle-substituted fused- heteroaryl compounds for the treatment of disease | |
NO20055591L (no) | Antivirale fosfonatanaloger | |
DE60124085D1 (de) | Pde-v hemmer zur behandlung von morbus parkinson | |
IS6459A (is) | Arýl sambrædd azapólýsýklísk efnasambönd | |
BR0312729A (pt) | Novos derivados de indol-3-enxofre | |
EA200600317A1 (ru) | Производные омега-карбоксиарилдифенилмочевины (варианты), фармацевтическая композиция (варианты) и способ лечения и предупреждения заболеваний и состояний с их использованием (варианты) | |
ATE307810T1 (de) | Imidazol-2-carbonsäureamid derivate als raf- kinase-inhibitoren | |
ATE389395T1 (de) | Substituierte 2-aminotetraline zur vorbeugenden behandlung von morbus parkinson | |
HK1080079A1 (en) | A process for the preparation of 2-methylpiperazine derivative | |
DK1745010T3 (da) | Substituerede cyklohexyl-1,4-diaminderivater | |
IL176915A0 (en) | Cycloalkyl substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, method for the production thereof and their use as medicaments | |
DE602006009556D1 (de) | Chinolin-derivate zur behandlung von mglur5-rezeptor-vermittelten erkrankungen | |
MXPA05010020A (es) | Derivados de oxamida. | |
EA200700707A1 (ru) | Производные 2-ациламинотиазола | |
MA27745A1 (fr) | Derives d'acide benzoylureidopyridyl-piperidine et pyrrolidinecarboxylique substitues, methode de production de ceux-ci et utilisation de ceux-ci. | |
DE602004019778D1 (de) | Verwendung von 2-amino-1,3-propandiolderivaten zur herstellung eines medikaments zur behandlung von bestimmten schmerzen | |
DE602006007682D1 (de) | 2,5-disubstituierte phenylmethanonderivative als glycintransporter-1-inhibitoren (glyt-1) zur behandlung von neurologischen und neuropsychiatrischen störungen | |
EA200401432A1 (ru) | Сложноэфирные производные декагидроизохинолин-3-карбоновой кислоты в качестве анальгетиков | |
ATE369849T1 (de) | Haloacetamidobenzoesäure derivate und deren verwendung zur behandlung von parasitären erkrankungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8327 | Change in the person/name/address of the patent owner |
Owner name: PROXIMAGEN LTD., LONDON, GB |